BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Drug Development

  “Outlook” Good as Company’s AMD Drug Bevacizumab Shines in Phase III

  Shares in the company climbed more than 30% premarket following the news of the study findings. The major reason is believed to be the performance of bevacizumab.

  August 3, 2021

   · 

  3 min read

   · 

  Brandon May
• 

  Business

  Eli Lilly in the News: COVID-19, Q2 and Ad Drama

  Eli Lilly and Company is in the news with positive Olumiant data in COVID-19, a drop in COVID-19 product sales for the quarter and a protest of one of their ads. Here’s a look.

  August 3, 2021

   · 

  3 min read

   · 

  Mark Terry
• 

  FDA

  FDA Hands Out Surprising Rejection of Meduxus and Medac’s Treosulfan

  The FDA’s Treosulfan rejection was surprising for both Meduxus and Medac. The FDA has provided a Complete Response Letter and made some recommendations.

  August 3, 2021

   · 

  2 min read

   · 

  Mark Terry
• 

  Deals

  Sanofi Cements mRNA Position with $3.2 Billion Translate Bio Deal

  With its acquisition, Sanofi aims to establish a firm toehold in the mRNA space by integrating dedicated research and development capabilities, chemistry, manufacturing and controls.

  August 3, 2021

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  BMS Pulls Istodax in Lymphoma After Trial Fails to Show Progression-Free Survival

  The company announced that it is withdrawing its peripheral T-cell lymphoma drug Istodax from the market after recent trials showed that it does not achieve its primary efficacy endpoint.

  August 3, 2021

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Business

  Computational Gastroenterology Company Raises $30 Million in Series A Round

  Iterative Scopes closed on a $30 million Series A round. It was led by new investor Obvious Ventures, with participation from Eli Lilly, Johnson & Johnson Innovation – JJDC, Breyer Capital and Seae Ventures, in addition to Lee Shapiro, Zach Weinberg and Nat Turner.

  August 3, 2021

   · 

  3 min read

   · 

  Mark Terry
• 

  Drug Development

  A Pivotal Moment for CRISPR in the Gene Editing Journey

  With this milestone, the field is now wide open for the next in vivo CRISPR success, and Editas is hoping that it will be in the ocular disease space.

  August 3, 2021

   · 

  6 min read

   · 

  Heather McKenzie
• 

  Business

  BeiGene Builds New Site in New Jersey; MorphoSys Expands Boston Presence

  BeiGene is building a new research and development and manufacturing facility on a 42-acre campus in New Jersey, while MorphoSys is now growing its presence in the greater Boston area.

  August 3, 2021

   · 

  3 min read

   · 

  Alex Keown
• 

  Policy

  Mayne Pharma Under Fire in Australia as Investors File Class-Action Lawsuit

  The filing accused Mayne Pharma, which also has operations in the U.S., of breaching disclosure obligations with regard to anti-competitive conduct.

  August 3, 2021

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Drug Development

  FDA Lifts Partial Clinical Hold on Novartis’ Gene Therapy Trial for Spinal Muscular Atrophy

  The FDA-initiated partial hold on Novartis’ gene therapy trial for spinal muscular atrophy has been lifted recently. Here’s everything you need to know about it.

  August 3, 2021

   · 

  3 min read

   · 

  Brandon May